The George Washington University School of Medicine and Health Sciences is one of only two sites chosen for the first clinical trial of the eOD-GT8 60mer HIV vaccine candidate. Read more about the specifics of this study in this article!
GW Serving as Site for HIV Vaccine Trial
Latest News
FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV
Mpox Vaccine Is Safe and Generates a Robust Antibody Response in Adolescents
Latest news about the results of the COVAIL trial regarding the Sanofi booster. GW participated as one of the many sites for this COVID-19 vaccine study.